MX4881E - Procedimiento para preparar derivados de aminoalcoholes heterociclicos - Google Patents

Procedimiento para preparar derivados de aminoalcoholes heterociclicos

Info

Publication number
MX4881E
MX4881E MX765135U MX513576U MX4881E MX 4881 E MX4881 E MX 4881E MX 765135 U MX765135 U MX 765135U MX 513576 U MX513576 U MX 513576U MX 4881 E MX4881 E MX 4881E
Authority
MX
Mexico
Prior art keywords
aminoalcohole
cyclic
derivatives
procedure
preparing hetero
Prior art date
Application number
MX765135U
Other languages
English (en)
Spanish (es)
Inventor
Georges Lambelin
Joseph Roba
Claude Gillet
Romeo Roncucci
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Continental Pharma filed Critical Continental Pharma
Publication of MX4881E publication Critical patent/MX4881E/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D327/00Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/06Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D337/00Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02Seven-membered rings
    • C07D337/06Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/08Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
MX765135U 1975-11-18 1976-11-17 Procedimiento para preparar derivados de aminoalcoholes heterociclicos MX4881E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7535217A FR2332010A1 (fr) 1975-11-18 1975-11-18 Amino-alcool heterocyclique, son sel et son procede de preparation

Publications (1)

Publication Number Publication Date
MX4881E true MX4881E (es) 1982-11-30

Family

ID=9162563

Family Applications (1)

Application Number Title Priority Date Filing Date
MX765135U MX4881E (es) 1975-11-18 1976-11-17 Procedimiento para preparar derivados de aminoalcoholes heterociclicos

Country Status (21)

Country Link
JP (2) JPS5297952A (nl)
AT (1) AT355566B (nl)
AU (1) AU510315B2 (nl)
BE (1) BE848496A (nl)
CA (1) CA1094088A (nl)
CH (2) CH623321A5 (nl)
DE (1) DE2651572C2 (nl)
DK (1) DK151330C (nl)
ES (1) ES453389A1 (nl)
FI (1) FI763265A (nl)
FR (1) FR2332010A1 (nl)
GB (1) GB1565080A (nl)
GR (1) GR62012B (nl)
IE (1) IE44265B1 (nl)
IL (1) IL50932A (nl)
MX (1) MX4881E (nl)
NL (1) NL180936C (nl)
NZ (1) NZ182665A (nl)
PT (1) PT65853B (nl)
SE (1) SE434744B (nl)
ZA (1) ZA766907B (nl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2512817A1 (fr) * 1981-09-17 1983-03-18 Roussel Uclaf Nouveaux derives de l'aminomethyl 1h-indole-4-methanol et leurs sels, leur procede de preparation, leur application a titre de medicaments, les compositions les renfermant et leurs intermediaires de preparation
US4622399A (en) * 1983-06-30 1986-11-11 American Home Products Corporation Bicyclo-heterocyclic nitrogen substituted aminoethanol derivatives
US4562200A (en) * 1983-06-30 1985-12-31 American Home Products Corporation 5(Indolyl) and 5(2,3-dihydroindolyl) substituted aminoethanols and their use as anti-hypertensives
US4521606A (en) * 1983-06-30 1985-06-04 American Home Products Corp. 5-Indolyl substituted aminoethanols
EP0567090B1 (en) 1992-04-24 2000-07-26 Takeda Chemical Industries, Ltd. Benzoxazepine derivatives as cholinesterase inhibitors
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5705515A (en) * 1994-04-26 1998-01-06 Merck & Co., Inc. Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5674891A (en) * 1994-07-27 1997-10-07 The Procter & Gamble Company Dihydrobenzothiophene compounds useful as anti-inflammatory agents
US5684002A (en) * 1994-09-07 1997-11-04 The Procter & Gamble Company Dihydorbenzofuran and related compounds useful as anti-inflammatory agents
WO1997025311A1 (fr) 1996-01-10 1997-07-17 Asahi Kasei Kogyo Kabushiki Kaisha Nouveaux composes tricycliques et compositions medicamenteuses contenant ces composes
US5684031A (en) * 1996-02-01 1997-11-04 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
US5672620A (en) * 1996-02-01 1997-09-30 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
WO1998033793A1 (fr) * 1997-01-30 1998-08-06 Sanofi-Synthelabo DERIVES DE α-AZACYCLOMETHYL BENZOTHIOPHENE ET DE α-AZACYCLOMETHYL BENZOFURANE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2758820B1 (fr) * 1997-01-30 1999-02-26 Synthelabo Derives de alpha-azacyclomethyl-benzofurane, leur preparation et leur application en therapeutique
WO1999001431A1 (fr) * 1997-07-03 1999-01-14 Asahi Kasei Kogyo Kabushiki Kaisha Nouveaux composes tricycliques presentant des noyaux satures et compositions medicinales les contenant
DK1277736T3 (da) 2000-04-28 2007-10-01 Asahi Kasei Pharma Corp Hidtil ukendte bicykliske forbindelser
DK1447400T3 (da) 2001-10-25 2008-12-08 Asahi Kasei Pharma Corp Bicyklisk forbindelse
CN102171192A (zh) 2008-10-09 2011-08-31 旭化成制药株式会社 吲唑化合物
CA2737349A1 (en) 2008-10-09 2010-04-09 Asahi Kasei Pharma Corporation Indazole derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1013224A (en) * 1962-06-21 1965-12-15 Ici Ltd Heterocyclic aminoethanols
US3255249A (en) * 1963-04-26 1966-06-07 Ici Ltd 2-branched lower alkyl-amino-1-(indan-, hydrogenated indan- and hydrogenated naphth-2-yl) lower alkanols
CH442302A (de) * 1964-04-17 1967-08-31 Sandoz Ag Verfahren zur Herstellung eines neuen Indolderivates
FR2138488A1 (en) * 1971-05-27 1973-01-05 Lipha 1-(5-indanyl)-omega-aminoalkanes - with tranquillizing activity

Also Published As

Publication number Publication date
JPS57145843A (en) 1982-09-09
ES453389A1 (es) 1977-11-16
IL50932A0 (en) 1977-01-31
IE44265L (en) 1977-05-18
PT65853A (fr) 1976-12-01
ZA766907B (en) 1977-10-26
AU1977976A (en) 1978-05-25
GR62012B (en) 1979-02-15
SE434744B (sv) 1984-08-13
AT355566B (de) 1980-03-10
FI763265A (nl) 1977-05-19
DE2651572A1 (de) 1977-06-08
JPS63435B2 (nl) 1988-01-07
JPS5297952A (en) 1977-08-17
CH623321A5 (en) 1981-05-29
JPS6017778B2 (ja) 1985-05-07
NL180936B (nl) 1986-12-16
BE848496A (fr) 1977-05-18
DE2651572C2 (de) 1982-05-19
FR2332010B1 (nl) 1979-06-29
SE7612554L (sv) 1977-05-19
DK517076A (da) 1977-05-19
NL180936C (nl) 1987-05-18
ATA854376A (de) 1979-08-15
GB1565080A (en) 1980-04-16
NZ182665A (en) 1978-11-13
AU510315B2 (en) 1980-06-19
PT65853B (fr) 1978-05-15
CH622770A5 (en) 1981-04-30
IE44265B1 (en) 1981-09-23
DK151330B (da) 1987-11-23
CA1094088A (en) 1981-01-20
FR2332010A1 (fr) 1977-06-17
IL50932A (en) 1984-01-31
NL7612794A (nl) 1977-05-23
DK151330C (da) 1988-04-25

Similar Documents

Publication Publication Date Title
MX4502E (es) Procedimiento para preparar 9alfa-hidroxiandrostenodiona
MX4047E (es) Procedimiento para preparar aralquilimidazoles
AR216898A1 (es) Procedimiento para preparar nuevas 1-amidino-3-fenilureas
MX4811E (es) Procedimiento para preparar derivados de prostaglandina
MX3638E (es) Procedimiento para preparar metilpirazolilamidas
MX4881E (es) Procedimiento para preparar derivados de aminoalcoholes heterociclicos
MX3654E (es) Procedimiento para preparar compuestos de sulfonilbencimidazol
MX4899E (es) Procedimiento para preparar derivados de espirohidantoina
MX3972E (es) Procedimiento para preparar compuestos de 2-aroil-3-fenilbenzotiofeno
MX3737E (es) Procedimiento para preparar compuestos de rifamacina
MX143361A (es) Procedimiento para preparacion de azinas
AR216438A1 (es) Procedimiento para preparar derivados de difenil-alquil-aza-bicicloalcano
AR221081A1 (es) Procedimiento para preparar derivados de fenoximetil-piperidino-propoxi-indol
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
AR218233A1 (es) Procedimiento para preparar composiciones rodenticidas
AR211013A1 (es) Procedimiento para preparar sderivados de rifamicina.
AR207582A1 (es) Procedimiento para preparar derivados de diaminociclitole
MX3832E (es) Procedimiento para preparar pirazolinonas
AR213419A1 (es) Procedimiento para preparar nuevos derivados de daunorubicina
MX144445A (es) Procedimiento para la obtencion de derivados de poliglicoleter no ionicos
MX4911E (es) Procedimiento para preparar derivados de quinoleina
MX143993A (es) Procedimiento mejorado para preparar triarilfosfinas
MX3513E (es) Procedimiento para preparar compuestos de formamidosulfenilanina
MX4291E (es) Procedimiento para preparar compuestos de aroil-fenilnaftaleno
MX4409E (es) Procedimiento para preparar derivados de cefalosporina